Background/Objectives: There were no available data about pathophysiology of refractory functional dyspepsia (FD). We have reported that refractory FD patients and, especially refractory epigastric pain syndrome (EPS) patients highly involve FD patients concomitant with pancreatic enzyme abnormalities. We tried to clarify whether clinical characteristics and pathophysiology in EPS alone patients were associated with pancreatic enzyme abnormalities.
Methods: We classified 112 FD patients into 21 EPS symptom alone, 28 PDS symptom alone, and 63 EPS-PDS overlapped patients who were initially presenting with anti-acid therapy-resistant FD symptoms. Clinical symptoms, anxiety and depressive state were estimated by GSRS, STAI and SRQ-D. Gastric emptying was evaluated. Five kinds of pancreatic enzyme such as amylase, lipase, trypsin, PLA2 and elastase-1 were measured.
Results: SRQ-D score, STAI-state and STAI-trait scores of EPS alone patients were significantly (p = 0.02, p = 0.03 and p = 0.01, respectively) higher than those of PDS alone patients. PCS and MCS of EPS alone patients were significantly lower than those of PDS alone patients (p = 0.04, p = 0.006). There were no significant differences in Tmax and T1/2 values between EPS alone patients and PDS alone patients. AUC5 and AUC15 values were significantly (p=0.003 and p = 0.005, respectively) disturbed in EPS alone patients compared to PDS alone patients. There were no significant differences in amylase, lipase, elastase-1, trypsin and PLA2 between EPS alone patients and PDS alone patients.
Conclusions: Although there were not significant differences in five kinds of pancreatic enzyme levels between EPS alone patients and PDS alone patients, measuring of early phase of gastric emptying may be a useful tool for the diagnosis of distinct two groups.
抄録全体を表示